SAB Biotherapeutics, Inc. (SABS)
3.715
-0.08
(-1.98%)
USD |
NASDAQ |
Aug 31, 16:00
3.715
0.00 (0.00%)
After-Hours: 20:00
SAB Biotherapeutics Price : 3.715 for Aug. 31, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 3.91 | 3.99 | 3.785 | 3.79 | 202596.0 |
| Aug 27, 2026 | 3.86 | 3.93 | 3.835 | 3.93 | 282217.0 |
| Aug 26, 2026 | 3.80 | 3.90 | 3.75 | 3.88 | 274419.0 |
| Aug 25, 2026 | 3.65 | 3.81 | 3.61 | 3.81 | 359374.0 |
| Aug 24, 2026 | 3.78 | 3.78 | 3.61 | 3.62 | 602686.0 |
| Aug 21, 2026 | 3.74 | 3.83 | 3.70 | 3.78 | 195670.0 |
| Aug 20, 2026 | 3.75 | 3.761 | 3.66 | 3.70 | 229628.0 |
| Aug 19, 2026 | 3.83 | 3.88 | 3.76 | 3.78 | 701272.0 |
| Aug 18, 2026 | 3.75 | 3.82 | 3.67 | 3.79 | 351303.0 |
| Aug 17, 2026 | 3.70 | 3.85 | 3.69 | 3.77 | 232028.0 |
| Aug 14, 2026 | 3.77 | 3.78 | 3.680 | 3.70 | 324657.0 |
| Aug 13, 2026 | 3.82 | 3.84 | 3.74 | 3.75 | 256872.0 |
| Aug 12, 2026 | 3.76 | 3.83 | 3.70 | 3.80 | 307681.0 |
| Aug 11, 2026 | 3.79 | 3.793 | 3.67 | 3.76 | 312038.0 |
| Aug 10, 2026 | 3.89 | 3.89 | 3.755 | 3.78 | 297355.0 |
| Aug 07, 2026 | 3.86 | 3.95 | 3.85 | 3.90 | 343908.0 |
| Aug 06, 2026 | 3.76 | 3.87 | 3.61 | 3.85 | 280362.0 |
| Aug 05, 2026 | 3.86 | 3.894 | 3.72 | 3.77 | 284308.0 |
| Aug 04, 2026 | 3.80 | 3.97 | 3.73 | 3.85 | 1.163M |
| Aug 03, 2026 | 3.59 | 3.855 | 3.505 | 3.79 | 676235.0 |
| Jul 31, 2026 | 3.56 | 3.58 | 3.42 | 3.57 | 405027.0 |
| Jul 30, 2026 | 3.49 | 3.59 | 3.464 | 3.56 | 208636.0 |
| Jul 29, 2026 | 3.43 | 3.545 | 3.395 | 3.48 | 371503.0 |
| Jul 28, 2026 | 3.40 | 3.49 | 3.35 | 3.45 | 241310.0 |
| Jul 27, 2026 | 3.53 | 3.635 | 3.43 | 3.44 | 609581.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 82.42 |
| Oncolytics Biotech, Inc. | 0.843 |
| Sangamo Therapeutics, Inc. | 0.1605 |
| Sarepta Therapeutics, Inc. | 21.03 |
| Anixa Biosciences, Inc. | 3.365 |
Price Related Metrics
| Price to Book Value | 1.444 |
| Earnings Yield | -44.69% |
| Market Cap | 310.18M |